Use of ubiquinone Q10 for the local treatment and prevention of post-surgical ophthalmologic pathologies

US6787572B2 · kind B2 · utility

Assignee

• Giuseppe Simonelli · IT

Inventors

• Rosario Brancato · Firenze, IT
• Sergio Capaccioli · Firenze, IT
• Marco Fabrizio Saettone · Viareggio, IT
• Nicola Schiavone · Firenze, IT

Key dates

• Filing date: Jul 9, 2001
• Grant date: Sep 7, 2004
• Expiry date: Jul 23, 2021

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K47/44
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

In the treatment of ophthalmologic pathologies in general and in particular in the treatment and prevention of side-effects on eye following photorefractive therapy (PRK), laser-assisted in situ keratomileusis (LASIK) and exposure to solar light and ultraviolet radiation, ubiquinone Q10 is utilized in a collyrium pharmaceutical preparation for ocular topical administration thereof.